Are you attending ISPOR May 15-18 in Washington, DC? Don’t miss any of the Precision workshops and poster presentations.
Click the title of each presentation below to learn more!
PRECISIONadvisors:
Posters:
- To Wait or Not to Wait: Foregone Option Value for Cell and Gene Therapies
- Authors: David Carr, Mary Wake, Dimitrios Tzaras
- When: Session begins on May 16, 2022 at 9:45 AM
- Access Barrier or Opportunity? Evolving Trends in NRDL Listings in China
- Authors: Richard Macaulay, Ka Wan Leong
- When: Session begins on May 16, 2022 at 9:45 AM
- Consequences of Brexit: Medicines Access to Northern Ireland
- Authors: Richard Macaulay, George Duo Wang, Ka Wan Leong
- When: Session begins on May 17, 2022 at 9:45 AM
- UK Market Access: The Evolving Scope of NICE and NHSE Specialised Commissioning
- Authors: Richard Macaulay, Ka Wan Leong
- When: Session begins on May 17, 2022 at 3:00 PM
PRECISIONheor:
Workshops:
- Systematic Approaches to Assessing Physician Decision-Making Practices and Treatment Preferences (#106)
- Participants: Katherine Batt, Marlon Graf, Suepattra May-Slater
- When: Monday, May 16 at 10:15-11:15 AM
- Measuring Health Equity: Lessons from an Integrated Healthcare System (#142)
- Participants: Alice Pressman, Kristen Azar, Stephen H. Lockhart
- When: Monday, May 16 at 4:30-5:30 PM
Posters:
- The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France
- Authors: Francis Pang, Rebecca Dean, Ivar Jensen, Andrew Olaye, Beck Miller
- When: Session begins on Monday, May 16 at 9:45 AM
- Budget Impact (BI) of First-Line (1L) Cemiplimab Monotherapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) with Programmed Cell Death-Ligand 1 (PD-L1) ≥50% in a Large US Health Plan: An Updated Analysis
- Authors: Ruben Quek, Chloi Theriou, Caitlin Smare, Sam Keeping, Yingxin Xu, Gerasimos Konidaris, Patrick LaFontaine, James Harnett
- When: Session begins on Tuesday, May 17 at 9:45 AM
- Number Needed to Treat Analysis of Nivolumab Versus Surveillance for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC)
- Authors: Prianka Singh, Sarah Kassahun, Kabirraaj Toor, Inkyu Kim, Sumie Kakehi, Elvira Estella-Pérez, Meena Venkatachalam
- When: Session begins on Tuesday, May 17 at at 9:45 AM
- Efficacy Outcomes Following Treatment with Bruton Tyrosine Kinase Inhibitors (BTKi) for Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): A Literature-Based Meta Analysis
- Authors: Martin Dreyling, B Shah, JJ Wu, Jenny MH Chen, Sam Keeping, Keith Chan, Sally Wade, Weimin Peng, Iona Kloos, M Wang
- When: Session begins on Tuesday, May 17 at at 9:45 AM
- Initial Treatment Patterns for Newly-Diagnosed Commercially Insured Patients with Psoriasis
- Authors: Laura Panattoni, Jennifer Hernandez, Yanmei Liu, Naomi C. Sacks, Robert Higham, Brett Stephenson, April Armstrong
- When: Session begins on Tuesday, May 17, 2022 at 3 PM
- Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)
- Authors: Jacki Chou, Eric Bell, Iris Brewer, Sree Appukkuttan, Jamie Partridge, Sheldon Kong, Ross Maclean
- When: Session begins on Wednesday, May 18, 2022 at 9 AM
- Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries
- Authors: Jason Shafrin, Anuj Mubayi, Kelly Birch, Natalie Land, Michelle Sotak, Meena Venkatachalam, Chloi Theriou, Michael Ayad
- When: Session begins on Wednesday, May 18 at 9 AM
